EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Break into the life science inner circle

BioPharm America is the premier conference for building relationships you need to get ahead. Engage with high-caliber strategic partners and investors to advance your startup company.

Meet more key decision makers in two days than you could all year!

USD 895* - Special Pricing for first-time Startups
  • Meet with investors and pharma executives in one-to-one meetings facilitated by the industry's leading partneringONE® system

  • Apply to pitch your innovation to top-tier venture capitalists, pharma and private equity investors at an exclusive pitch competition for startups

  • Access advice from experts to help you lay the groundwork for your launch or commercialization strategy

  • Network and build relationships during evening events

  • Be part of the global life science community through exclusive access to keynotes and evening events during concurrent Biotech Week Boston September 4–7

*Special rate only applies to first-time attendees. To qualify, eligible companies must meet the following criteria:

  • Have been created in the past five years
  • Have fewer than ten employees
  • Be developing new therapeutic products, technology platforms or digital medicine technologies
  • Have aggregate financing of USD 12 million or less.

Success or failure depends on you: Get advice from the experts to help your startup succeed


Download the Startup Manual now

Plus, meet these startups!

GET NOTICED. GET FUNDED.

Pitch your startup to a panel of judges comprising top-tier venture capitalists, pharma representatives and private equity investors!

For just USD 150 more, qualifying startup companies are invited to apply to pitch their innovations to our reputable panel of judges.

FOR MORE INFORMATION, CONTACT: